Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can early sexual health counseling transform breast cancer recovery?

NCT ID NCT06583460

Symptom relief Sponsor: Center Eugene Marquis Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial asks whether starting sexual health support early and systematically helps women with localized breast cancer feel better about their sexual well-being compared to waiting until they ask for help. Women aged 18 and older who are beginning treatment with surgery will receive either early, structured care from a sexologist and anthropologist or standard on-demand care. The study measures sexual satisfaction using a validated questionnaire to see if proactive support makes a meaningful difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Early and systematic oncosexological supportive care, including interviews with an anthropologist and consultations with a sexologist
What this could lead to
If effective, this approach could establish early, structured sexual health support as a standard part of breast cancer care, improving quality of life for many women.
What could go wrong
The trial is small (60 participants) and measures subjective outcomes, so results may not be conclusive or widely applicable. The intervention's benefit over on-demand care remains uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Dec 2024

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women ≥ 18 years (menopausal or not), * Localized breast cancer with or without lymph node involvement, * Initial treatment starting with surgical resection, whatever the associated therapy (chemotherapy, radiotherapy, hormone therapy, monoclonal antibody, conjugated drug antibody, targeted therapy such as cyclin and anti-PARP inhibitors, etc.), * Patient affiliated or benefiting from the social security system, * Patient informed and informed consent signed. Exclusion Criteria: * History of cancer (except squamous cell carcinoma or basal cell carcinoma) in the last five years, * Pregnant or breast-feeding women, * Patients deprived of their liberty, under guardianship or curatorship and all other administrative safeguards, * Patients unable to comply with the study schedule for social, medical or psychological reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer female are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer female breast carcinoma physiological sexual disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer female Localized cancer

Contacts and locations

Locations

  • Centre de Lutte contre le Cancer Eugène Marquis

    Rennes, Brittany Region, 35042, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.